SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules.
Emerging biopharma work at the forefront of science, often venturing into disease areas where little or no real-world data exists to work with or regulatory frameworks to work within.
Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their R&D goals
Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.
Peptide synthesis and the hidden complexities of scaling peptide therapeutics, from SPPS to purification, analytics, and cGMP manufacturing. Talk to our team today.
Discover how Project Optimus is changing oncology drug development through data-driven dose optimization and modeling strategies. Learn more today.
